BioTime Strong Sell Recommendation Published in Forbes.

Asensio & Company, Inc.’s strong sell recommendation was published in the January 26, 1998 issue of Forbes in the Money & Investments section. The recommendation was given based on the opinion that the Company has very limited earnings and sales potential, and that it has excessively and fraudulently promoted the value of Hextend, its commodity-based plasma extender product.

Short selling involves a risk not associated with the purchase of stock including, but not only limited to, unlimited loss and stock borrowing risks. Additional information is available upon request.